HELIX alpha

Company posts

HELIX alpha publishes a white paper on the classification of life sciences real estate as an institutional investment

HELIX alpha has published a white paper that categorises life sciences property for institutional investors. It compares shell/core models with operated laboratory platforms and emphasises location and building quality in relation to the risk-return profile. Available in German and English.

HELIX alpha Strengthens Executive Board and Expands European Life Science Real Estate Platform with Advisory

HELIX alpha is expanding its life science real estate platform to include advisory and strengthening the management team. On October 1, 2026, Patrick Schlump will move as managing partner. Dr. Thomas Diefenthal will take on an operational role as Director Advisory.

Dynamics